Diadema Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$69.4K Buy
+60
New +$70.8K 0.01% 135
2026
Q2
– Sell
-6,000
Closed -$6.13M – 177
2026
Q1
$5.52M Buy
6,000
+4,000
+200% +$4.06M 0.94% 36
2025
Q4
$2.15M Buy
+2,000
New +$1.91M 0.37% 61
2025
Q3
– Sell
-14,816
Closed -$11M – 147
2025
Q2
$11.5M Sell
14,816
-4,486
-23% -$3.49M 3.52% 7
2025
Q1
$15.9M Buy
+19,302
New +$16.1M 4.16% 7

Other funds holding LLY

Diadema Partners's LLY Position: Q3 2026 in Review

Diadema Partners opened a new position in Eli Lilly (LLY) in Q3 2026: 60 shares worth $69.4K. The stake represents 0.01% of the portfolio and ranks #135 among its holdings. This is a return to the name: Diadema Partners previously reported a position in LLY as recently as Q1 2026.

Diadema Partners first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $15.9M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Diadema Partners held 60 shares of Eli Lilly worth $69.4K as of Q3 2026.
  • Eli Lilly was a new Diadema Partners position in Q3 2026.
  • Eli Lilly made up 0.01% of Diadema Partners's portfolio in Q3 2026, its #135 holding.
  • Diadema Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Diadema Partners's Eli Lilly position peaked at $15.9M in Q1 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Diadema Partners's 13F filing for Q3 2026, filed 16 Nov 2026.